What is Matreya?
Matreya operates as a critical supplier within the scientific research ecosystem, specializing in the provision of high-quality assay kits, antibodies, biochemicals, and proteins. By bridging the gap between raw laboratory requirements and advanced research outcomes, the company serves a diverse clientele across the scientific community. Beyond its product portfolio, Matreya distinguishes itself through the delivery of specialized contract research services, which provide essential support for complex experimental workflows. This dual-pronged approach—combining high-purity material supply with technical research expertise—positions the company as a foundational partner for institutions engaged in rigorous scientific inquiry and development.
How much funding has Matreya raised?
Matreya has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Matreya
PPP
Public-Private Partnership
What's next for Matreya?
Following this late-stage funding round, Matreya is expected to prioritize the scaling of its research infrastructure and the enhancement of its supply chain logistics. The strategic allocation of these funds will likely focus on increasing the throughput of its contract research division and broadening its catalog of biochemical reagents. As the company navigates this growth phase, the emphasis will remain on maintaining the high standards of quality that have become synonymous with its brand. By leveraging this capital, Matreya aims to solidify its market share and address the evolving demands of the global research community, ensuring that its clients have the necessary tools to drive innovation in their respective fields.
See full Matreya company page
